CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $2.1M of Cerevel Therapeutics Holdings, Inc.
Sold$2,116,640
$42.33Price
50,000Shares
−76%Stake
What CERE did after the filing
- The stock from Wed, Apr 3 close, $42.33
- 0.0%
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the May 15 close.
Traded Mon, Apr 1. Filed Wed, Apr 3, 12:15 PM ET, during the session. Returns use the Apr 3 close and the May 15 close. Not investment advice.